217 related articles for article (PubMed ID: 22083206)
1. Suppression of antigen-specific CD4+ T cell activation by SRA/CD204 through reducing the immunostimulatory capability of antigen-presenting cell.
Yi H; Zuo D; Yu X; Hu F; Manjili MH; Chen Z; Subjeck JR; Wang XY
J Mol Med (Berl); 2012 Apr; 90(4):413-26. PubMed ID: 22083206
[TBL] [Abstract][Full Text] [Related]
2. Absence of scavenger receptor A promotes dendritic cell-mediated cross-presentation of cell-associated antigen and antitumor immune response.
Guo C; Yi H; Yu X; Hu F; Zuo D; Subjeck JR; Wang XY
Immunol Cell Biol; 2012 Jan; 90(1):101-8. PubMed ID: 21383767
[TBL] [Abstract][Full Text] [Related]
3. CD204 suppresses large heat shock protein-facilitated priming of tumor antigen gp100-specific T cells and chaperone vaccine activity against mouse melanoma.
Qian J; Yi H; Guo C; Yu X; Zuo D; Chen X; Kane JM; Repasky EA; Subjeck JR; Wang XY
J Immunol; 2011 Sep; 187(6):2905-14. PubMed ID: 21832164
[TBL] [Abstract][Full Text] [Related]
4. Pattern recognition scavenger receptor SRA/CD204 down-regulates Toll-like receptor 4 signaling-dependent CD8 T-cell activation.
Yi H; Yu X; Gao P; Wang Y; Baek SH; Chen X; Kim HL; Subjeck JR; Wang XY
Blood; 2009 Jun; 113(23):5819-28. PubMed ID: 19349620
[TBL] [Abstract][Full Text] [Related]
5. Targeting the immunoregulator SRA/CD204 potentiates specific dendritic cell vaccine-induced T-cell response and antitumor immunity.
Yi H; Guo C; Yu X; Gao P; Qian J; Zuo D; Manjili MH; Fisher PB; Subjeck JR; Wang XY
Cancer Res; 2011 Nov; 71(21):6611-20. PubMed ID: 21914786
[TBL] [Abstract][Full Text] [Related]
6. Expression of scavenger receptor A on antigen presenting cells is important for CD4+ T-cells proliferation in EAE mouse model.
Levy-Barazany H; Frenkel D
J Neuroinflammation; 2012 Jun; 9():120. PubMed ID: 22676725
[TBL] [Abstract][Full Text] [Related]
7. Pattern recognition scavenger receptor CD204 attenuates Toll-like receptor 4-induced NF-kappaB activation by directly inhibiting ubiquitination of tumor necrosis factor (TNF) receptor-associated factor 6.
Yu X; Yi H; Guo C; Zuo D; Wang Y; Kim HL; Subjeck JR; Wang XY
J Biol Chem; 2011 May; 286(21):18795-806. PubMed ID: 21460221
[TBL] [Abstract][Full Text] [Related]
8. In situ vaccination with CD204 gene-silenced dendritic cell, not unmodified dendritic cell, enhances radiation therapy of prostate cancer.
Guo C; Yi H; Yu X; Zuo D; Qian J; Yang G; Foster BA; Subjeck JR; Sun X; Mikkelsen RB; Fisher PB; Wang XY
Mol Cancer Ther; 2012 Nov; 11(11):2331-41. PubMed ID: 22896667
[TBL] [Abstract][Full Text] [Related]
9. CD11c(+) dendritic cells maintain antigen processing, presentation capabilities, and CD4(+) T-cell priming efficacy under hypercholesterolemic conditions associated with atherosclerosis.
Packard RR; Maganto-García E; Gotsman I; Tabas I; Libby P; Lichtman AH
Circ Res; 2008 Oct; 103(9):965-73. PubMed ID: 18832748
[TBL] [Abstract][Full Text] [Related]
10. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
Bodey B; Bodey B; Kaiser HE
In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
[TBL] [Abstract][Full Text] [Related]
11. Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activation.
Hirosue S; Kourtis IC; van der Vlies AJ; Hubbell JA; Swartz MA
Vaccine; 2010 Nov; 28(50):7897-906. PubMed ID: 20934457
[TBL] [Abstract][Full Text] [Related]
12. The role of antigen-presenting cells and interleukin-12 in the priming of antigen-specific CD4+ T cells by immune stimulating complexes.
Robson NC; Beacock-Sharp H; Donachie AM; Mowat AM
Immunology; 2003 Sep; 110(1):95-104. PubMed ID: 12941146
[TBL] [Abstract][Full Text] [Related]
13. Retrovirally transduced mouse dendritic cells require CD4+ T cell help to elicit antitumor immunity: implications for the clinical use of dendritic cells.
Schnell S; Young JW; Houghton AN; Sadelain M
J Immunol; 2000 Feb; 164(3):1243-50. PubMed ID: 10640737
[TBL] [Abstract][Full Text] [Related]
14. Nontoxic Shiga toxin derivatives from Escherichia coli possess adjuvant activity for the augmentation of antigen-specific immune responses via dendritic cell activation.
Ohmura M; Yamamoto M; Tomiyama-Miyaji C; Yuki Y; Takeda Y; Kiyono H
Infect Immun; 2005 Jul; 73(7):4088-97. PubMed ID: 15972497
[TBL] [Abstract][Full Text] [Related]
15. Limiting dilution analysis of CD4 T-cell cytokine production in mice administered native versus polymerized ovalbumin: directed induction of T-helper type-1-like activation.
Gieni RS; Yang X; Kelso A; Hayglass KT
Immunology; 1996 Jan; 87(1):119-26. PubMed ID: 8666423
[TBL] [Abstract][Full Text] [Related]
16. Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity.
He T; Tang C; Xu S; Moyana T; Xiang J
Cell Mol Immunol; 2007 Apr; 4(2):105-11. PubMed ID: 17484804
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of T cell tolerance induction by murine hepatic Kupffer cells.
You Q; Cheng L; Kedl RM; Ju C
Hepatology; 2008 Sep; 48(3):978-90. PubMed ID: 18712788
[TBL] [Abstract][Full Text] [Related]
18. Splenic dendritic cells pulsed with Ixodes ricinus tick saliva prime naive CD4+T to induce Th2 cell differentiation in vitro and in vivo.
Mejri N; Brossard M
Int Immunol; 2007 Apr; 19(4):535-43. PubMed ID: 17344202
[TBL] [Abstract][Full Text] [Related]
19. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules.
Shen X; Niu C; König R
Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721
[TBL] [Abstract][Full Text] [Related]
20. Scavenger receptor A restrains T-cell activation and protects against concanavalin A-induced hepatic injury.
Zuo D; Yu X; Guo C; Wang H; Qian J; Yi H; Lu X; Lv ZP; Subjeck JR; Zhou H; Sanyal AJ; Chen Z; Wang XY
Hepatology; 2013 Jan; 57(1):228-38. PubMed ID: 22821642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
